CATALYST CLINSUITE Trademark

Trademark Overview

On Friday, March 26, 2021, a trademark application was filed for CATALYST CLINSUITE with the United States Patent and Trademark Office. The USPTO has given the CATALYST CLINSUITE trademark a serial number of 90606013. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 9, 2024. This trademark is owned by Catalyst Clinical Research LLC. The CATALYST CLINSUITE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) featuring software for managing clinical trials
catalyst clinsuite

General Information

Serial Number90606013
Word MarkCATALYST CLINSUITE
Filing DateFriday, March 26, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2021

Trademark Statements

Goods and ServicesSoftware as a service (SAAS) featuring software for managing clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCatalyst Clinical Research LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, NC 28409
Party NameCatalyst Clinical Research LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, NC 28409

Trademark Events

Event DateEvent Description
Tuesday, March 30, 2021NEW APPLICATION ENTERED
Friday, July 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Friday, November 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 14, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 8, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 8, 2022SOU EXTENSION 1 FILED
Monday, August 8, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 7, 2023SOU EXTENSION 2 FILED
Tuesday, February 7, 2023SOU EXTENSION 2 GRANTED
Thursday, February 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2024SOU EXTENSION 4 FILED
Tuesday, February 6, 2024SOU EXTENSION 4 GRANTED
Thursday, February 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 8, 2023SOU EXTENSION 3 FILED
Tuesday, August 8, 2023SOU EXTENSION 3 GRANTED
Tuesday, May 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 9, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 9, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, May 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

clinsuite catalyst software clinical trials managing featuring service saas